It is postulated, that the inhibition of NF-κB through CK2 inhibition enables indirect tumor targeting by shifting macrophages from the tumor-tolerating M2-polarization stage towards the tumor-attacking M1-stage. This evidence concerns the gene NFKB1 and neoplasm.